AXPAXLI for Diabetic Retinopathy
Retina Synthesis - Podcast autorstwa Retina Synthesis
Kategorie:
We discuss the promising phase I results of the Helios trial studying AXPAXLI TKI inhibitor implant for diabetic retinopathy with Dr. Dilsher Dhoot of California Retina Consultants.
